Natera, Inc. (NTRA) is an American biotechnology company specializing in the development and production of non-invasive genetic tests. With advanced technologies in reproductive medicine, oncology, and transplantation, Natera provides accurate and reliable tests for prenatal screening, detection of tumor markers, and transplant monitoring. The company is known for its focus on innovation and the use of advanced bioinformatics tools, enabling it to deliver high-quality genetic testing. Natera also collaborates with medical institutions and research organizations to enhance diagnostic capabilities. Natera, Inc. (NTRA) shares could be suitable for investors looking for opportunities in the biotechnology sector with a focus on genetic testing and innovations in non-invasive diagnostics.